COVID-19 toolkit to boost vaccine development and research
An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow...
An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow...
Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate for COVID-19
Griffith University and Queensland-based Luina Bio has announced they have entered into a Memorandum of Understanding (MoU) targeting the development...
Initial success in human clinical trials has given hope for the next stage in the development of a new malaria vaccine.
A team of Griffith University researchers has received more than $1 million to find new vaccine targets for diseases which cause meningitis, gonorrhoea and middle ear infections.
Sanofi has progressed its partnership with Griffith by officially opening its latest research site at the university’s Gold Coast campus.
Pictured left to right: Professor Michael Good AO, PDG Sandy Doumany OAM, Associate Professor Danielle Stanisic, Her Excellency the Honourable...
Griffith researchers among 19 scientists share in $5.56 million of funding.
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.